- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
心脏死亡儿童供体单肾移植的疗效分析
1.中南大学湘雅三医院湖南长沙410013
摘 要 目的评估供体年龄在2岁以上的心脏死亡儿童供体单肾移 植(SPKT)的临床疗效,并探讨其应用价值。方法回顾性分析我中心自2010 年到2014年开展的26例SPKT和109例心脏死亡标准供体肾移植(SCDKT)o对 比两种肾移植术后供受体的基木资料及术后早期并发症的发牛率,比较、分析两 种肾移植术后1年内移植肾的长径、功能、移植肾存活率和受者存活率之间的差 异,评估心脏死亡儿童供体单肾移植的临床疗效。结果SPKT组与SCDKT组术 后早期并发症的发牛率无明显差异(Pgt;0.05); SPKT术后移植肾的成长能力明 显优于SCDKT组;两组术后各时间点的肾小球滤过率(eGFR)、移植肾存活率及 人存活率之间均无统计学差异(Pgt;0.05)o结论当心脏死亡儿童供体的年龄 大于2岁时,SPKT不仅术后移植肾有良好的成长能力,其临床疗效也可与SCDKT 相媲美,是尿毒症患者的理想选择,其合理应用有助于扩大器官来源。
关键词 心脏死亡捐献;儿童供体;肾移植;体表面积
The analysis of outcomes on single pediatric kidney transplantation from cardiac death deceased donors
Zhi-tanPENGl, Qi-fa YE1, Ke CHENG1, Yu-jun ZHAO1, Lian LIU1, Qiang WANG1
(l.The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013;)
Abstractobjective To analyze the outcomes and discuss the application of single pediatric kidney transplantation (SPKT) from cardiac death deceased donors (2-18yr).
Methods We retrospectively analyzed 26 cases of SPKT from cardiac death deceased donors and 109 cases of standard-criteria donor kidney transplantation (SCDKT) that were performed in our center from 2010 through 2O14.We analyzed the outcomes of
SPKT by con ducting comparis on betwee n SPKT and SCDKT in demographics of patients, early postoperative complications, the length and function of grafts, and graft and patient survival.
Results There was no difference between SPKT and SCDKT in postoperative complications (Pgt;0.05) .The length of graft within half a year in SPKT was much shorter than that of SCDKT (Plt;0.05), however, the length of each group became almost equivalent as time went on.No sign 讦 icant d iff ere nee was show n betwee n each group in eGFR, graft and patient survival post kidney transplantation.
Conclusion Once the age of pediatric donors is above 2 yrs, the SPKT can obtain comparable outcomes to SCDKT and better capacity of graft growth, which is an ideal choice for uremia patients.Appropriate use of pediatric donors can significantly expand the donor pool.
文档评论(0)